PDL BioPharma Inc (NASDAQ:PDLI)

2.93
Delayed Data
As of 4:00pm ET
 +0.03 / +1.03%
Today’s Change
2.05
Today|||52-Week Range
3.55
+6.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues585.0M585.1M239.7M320.1M
 
 
 
 
 
Cost of Goods Sold----4.1M30.5M
 
 
 
Depreciation And Amortization----12.0M24.7M
 
 
 
 
Operating ExpensesGross Income----223.6M264.8M
 
 
 
General Expenses34.9M36.1M44.1M70.7M
 
 
 
 
 
Other Operating Expenses0.004.0M0.000.00
 
 
Research And Development----3.8M7.4M
 
 
 
Total Operating Expenses34.9M40.1M60.2M125.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income550.1M545.0M179.4M194.1M
 
 
 
 
 
Extraordinary Credit0.006.5M6.5M0.00
 
 
 
Extraordinary Charge-6.1M---60.7M-349.0K
 
 
 
 
Interest Expense On Debt39.2M27.1M20.8M20.2M
 
 
 
 
 
Other Expenses-3.8M5.8M4.9M11.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income501.3M530.1M109.4M184.5M
 
 
 
 
 
Income Taxes-179.0M-197.3M-45.7M-73.8M
 
 
 
 
 
Minority Interest0.000.00-53.0K-47.0K
 
 
 
Net Income322.2M332.8M63.6M110.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS158.2M163.4M163.8M155.4M
 
 
 
 
 
Shares To Calculate EPS Diluted173.1M163.6M164.2M156.3M
 
 
 
 
 
 
Earnings Per ShareEPS$1.86$2.03$0.39$0.71
 
 
 
 
 
EPS Diluted$1.86$2.03$0.39$0.71